From the blog

Studying the Clinical Trial Experiences of Patients With Mesothelioma

Published: April 21, 2023

Primary Outcome Measures

  1. Rate of patients who decide to enroll in a mesothelioma medical study. [ Time Frame: 3 months ]
  2. Number of mesothelioma patients who remain in clinical trial until completion. [ Time Frame: 12 months ]

Inclusion Criteria

  • Must have a medical diagnosis of mesothelioma that has been confirmed by a physician.
  • Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed.
  • Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.

Exclusion Criteria

  • Pregnant or lactating woman
  • Patients with any significant history of non-compliance to medical regimens or with inability to grant a reliable informed consent.
  • Known medical condition that, in the investigator’s opinion, would increase the risk associated with study participation or study drug(s) administration or interfere with the interpretation of safety results
Contact Us
Have you received a diagnosis? *